Related Experiment Video
Updated: Nov 10, 2025

Functional Characterization of RING-Type E3 Ubiquitin Ligases In Vitro and In Planta
Published on: December 5, 2019
Structural Model for Recruitment of RIT1 to the LZTR1 E3 Ligase: Evidences from an Integrated Computational Approach
Antonella Paladino1, Fulvio D'Angelo1,2, Teresa Maria Rosaria Noviello1,3
1BIOGEM Istituto di Ricerche Genetiche "G. Salvatore", via Camporeale, Ariano Irpino 83031, Italy.
Abstract:
Leucine-zipper transcription regulator 1 (LZTR1) is a highly mutated tumor suppressor gene, involved in the pathogenesis of several cancer types and developmental disorders. In proteasomal degradation, it acts as an adaptor protein responsible for the recognition and recruitment of substrates to be ubiquitinated in Cullin3-RING ligase E3 (CRL3) machinery. LZTR1 belongs to the BTB-Kelch family, a multi-domain protein where the Kelch propeller plays as the substrate recognition region and for which no experimental structure has been solved. Recently, large effort mutational analyses pointed to the role of disease-associated LZTR1 mutations in the RAS/MAPK signaling pathway and RIT1, a small Ras-related GTPase protein, has been identified by mass spectroscopy to interact with LZTR1. Hence, a better understanding of native structure, molecular mechanism, and substrate specificity would help clarifying the role of LZTR1 in pathological diseases, thus promoting advancement in the development of novel therapeutic strategies. Here, we address the interaction model between adaptor LZTR1 and substrate RIT1 by applying an integrated computational approach, including molecular modeling and docking techniques. We observe that the interaction model LZTR1-RIT1 is stabilized by an electrostatic bond network established between the two protein surfaces, which is reminiscent of homologous ubiquitin ligases complexes. Then, running MD simulations, we characterize differential conformational dynamics of the multi-domain LZTR1, offering interesting implications on the mechanistic role of specific point mutations. We identify G248R and R283Q as damaging mutations involved in the recognition process of the substrate RIT1 and R412C as a possible allosteric mutation from the Kelch to the C-term BTB-domain. Our findings provide important structural insights on targeting CRL3s for drug discovery.
Insights
Leucine-zipper transcription regulator 1 (LZTR1) protein interactions were modeled computationally. This study reveals how LZTR1 mutations impact substrate recognition, offering insights into cancer and developmental disorders for new therapeutic strategies.
Area of Science:
- Molecular biology
- Structural biology
- Computational biology
Background:
- Leucine-zipper transcription regulator 1 (LZTR1) is a tumor suppressor gene implicated in cancers and developmental disorders.
- LZTR1 functions as an adaptor protein in the Cullin3-RING ligase E3 (CRL3) complex, facilitating substrate ubiquitination and proteasomal degradation.
- The Kelch propeller domain of LZTR1 is crucial for substrate recognition, but its structure remains experimentally unsolved.
Purpose of the Study:
- To elucidate the interaction model between LZTR1 and its substrate RIT1 using computational methods.
- To understand the structural basis of LZTR1 function and the impact of disease-associated mutations.
- To provide insights for developing novel therapeutic strategies targeting CRL3 machinery.
Main Methods:
- Integrated computational approach combining molecular modeling and docking techniques.
- Molecular dynamics (MD) simulations to analyze conformational dynamics of LZTR1.
- Identification and characterization of key interactions and mutation effects.
Main Results:
- The LZTR1-RIT1 interaction is stabilized by an electrostatic bond network.
- MD simulations revealed differential conformational dynamics of LZTR1.
- Specific mutations (G248R, R283Q) were identified as damaging to RIT1 substrate recognition, while R412C may act as an allosteric mutation.
Conclusions:
- The study provides crucial structural insights into the LZTR1-RIT1 interaction mechanism.
- Findings highlight the role of specific LZTR1 mutations in disease pathogenesis.
- The results support targeting CRL3 complexes for drug discovery in cancer and developmental disorders.

